Cookie Consent by PrivacyPolicies.com

RENAL RESEARCH INSTITUTE

A highly diverse
team imagining
the undiscovered

ABOUT THE RENAL RESEARCH INSTITUTE

The heart of RRI’s capacity for innovation is our ability to examine complex problems through multiple lenses.

The Renal Research Institute (RRI) is an internationally recognized incubator of ideas, treatment processes, and technologies to improve the lives of kidney patients. RRI’s leadership in computational biomedicine and data analytics, as well as our access to a large patient population, accelerates the pace of scientific discoveries and their translation into applied medicine. Our team includes some of the brightest minds from around the world, who, along with their disciplinary expertise, bring a deep understanding of global healthcare issues and challenges.

THE RENAL RESEARCH INSTITUTE’S 
23RD INTERNATIONAL CONFERENCE ON

Dialysis Advances in Kidney Disease 2021

Jointly provided by Amedco, LLC & Columbia University

Latest Research & News

Displaying 1 articles
  • Latest Research

    View All
    Journal of the American Society of Nephrology
    Mar 08, 2021
    Alhaji Cherif, Joanna L. Willetts, Len Usvyat, Yue...

    Chronic hemodialysis is a life-sustaining therapy, delivered mostly thrice weekly in dialysis clinics. For patients on dialysis who appear to have a heightened likelihood of severe infection or death from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), travel to these facilities and proximity to fellow patients and health care providers during hemodialysis may pose an...

Displaying 1 articles
  • Latest News

    View All
    Matthew G. Sampson, Caroline S. Fox

    In both clinical care and research, genetics and genomics are no longer solely in the domain of geneticists and basic science researchers. On the clinical side, there is expanding recognition of the utility of genetic testing in patients with kidney disease and an increased ability to order it. As such, the number of patients who...

Education

Displaying 1 articles
  • LATEST EPISODE

    Aug 25, 2021

    Creatinine: old molecule, new insights.

    In this session join Drs. Peter Kotanko and Bernard Canaud discuss the suggestion that monthly monitoring of SCI, as part of routine baseline dialysis patient monitoring, will offer a new and cost-effective tool to detect earlier nutritional status deterioration. SCI used as a surrogate marker of active MM would facilitate detection of sarcopenia trends, offering opportunities to implement interventions that might delay, and halt or even reverse such deleterious dynamics. SCI can be easily integrated and used as a first-line tool in complement to visceral proteins (i.e., albumin) to monitor muscle mass changes in clinical routine
    In this session join Drs. Peter Kotanko and Bernard Canaud discuss the suggestion that monthly monitoring of SCI, as part of routine baseline dialysis patient monitoring, will offer a new and cost-effective tool to detect earlier nutritional status deterioration. SCI used as a surrogate marker of active MM would facilitate detection of sarcopenia trends, offering opportunities to implement interventions that might delay, and halt or even reverse such deleterious dynamics. SCI can be easily integrated and used as a first-line tool in complement to visceral proteins (i.e., albumin) to monitor muscle mass changes in clinical routine

cme

Recent Tweets